C-reactive protein levels: A prognostic marker for patients with head and neck cancer?

Head and Neck Oncology

Volumn 2, Issue 1, 2010, Pages

  Kruse, Astrid L ^a   Luebbers, Heinz T ^a   Grätz, Klaus W ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PRECANCER; PREOPERATIVE EVALUATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; SCHOOL CHILD; SQUAMOUS CELL CARCINOMA; WART VIRUS; ADOLESCENT; BLOOD; HEAD AND NECK TUMOR; KAPLAN MEIER METHOD; METABOLISM; PATHOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CARCINOMA, SQUAMOUS CELL; CHILD; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 77955669339     PISSN: None     EISSN: 17583284     Source Type: Journal    
DOI: 10.1186/1758-3284-2-21     Document Type: Article

References (18)

1. Inflammation and cancer. LM Coussens Z Werb, Nature 2002 420 860 867 10.1038/nature01322 12490959
2. Epidemiology of non-steroidal anti-inflammatory drugs and cancer. JA Baron, Prog Exp Tumor Res 2003 37 1 24 full-text 12795046
3. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. C Siemes LE Visser JW Coebergh TA Splinter JC Witteman AG Uitterlinden A Hofman HA Pols BH Stricker, J Clin Oncol 2006 24 5216 5222 10.1200/JCO.2006.07.1381 17114654 (Pubitemid 46631365)
4. WBC count and the risk of cancer mortality in a national sample of U.S. adults: results from the Second National Health and Nutrition Examination Survey mortality study. TP Erlinger P Muntner KJ Helzlsouer, Cancer Epidemiol Biomarkers Prev 2004 13 1052 1056 15184263
5. A prospective study of serum C-reactive protein and colorectal cancer risk in men. MJ Gunter R Stolzenberg-Solomon AJ Cross MF Leitzmann S Weinstein RJ Wood J Virtamo PR Taylor D Albanes R Sinha, Cancer Res 2006 66 2483 2487 10.1158/0008-5472.CAN-05-3631 16489056
6. Is C-reactive protein a prognostic factor of colorectal cancer? YC Shiu JK Lin CJ Huang JK Jiang LW Wang HC Huang SH Yang, Dis Colon Rectum 2008 51 443 449 10.1007/s10350-007-9133-z 18172726
7. C-reactive protein levels are not associated with increased risk for colorectal cancer in women. SM Zhang JE Buring IM Lee NR Cook PM Ridker, Ann Intern Med 2005 142 425 432 15767620
8. Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus. I Gockel K Dirksen CM Messow T Junginger, World J Gastroenterol 2006 12 3746 3750 16773693
9. Clinicopathological features of early esophageal squamous cell carcinoma with subsequent recurrence. T Nozoe H Saeki T Ohga K Sugimachi, Dis Esophagus 2002 15 145 148 10.1046/j.1442-2050.2002.00241.x 12220422 (Pubitemid 35264637)
10. Interleukin-6 and acute-phase proteins in head and neck cancer. O Gallo AM Gori M Attanasio F Martini B Giusti T Brunelli E Gallina, Eur Arch Otorhinolaryngol 1995 252 159 162 10.1007/BF00178104 7544987
11. Serum Levels of IL-1b, IL-6, TNF-a, sTNF-RI and CRP in Patients with Oral Cavity Cancer. E Jablonska L Piotrowski Z Grabowska, Pathol Oncol Res 1997 3 126 129 10.1007/BF02907807 11173639
12. Serum C-reactive protein as a prognostic indicator in patients with oral squamous cell carcinoma. SD Khandavilli PO Ceallaigh CJ Lloyd R Whitaker, Oral Oncol 2009 45 912 914 10.1016/j.oraloncology.2009.03.015 19502100
13. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma. Y Komai K Saito K Sakai S Morimoto, BJU Int 2007 99 77 80 10.1111/j.1464-410X.2006.06497.x 16956357
14. Association of C-reactive protein levels and long-term survival after neoadjuvant therapy and esophagectomy for esophageal cancer. U Zingg J Forberger B Rajcic C Langton GG Jamieson, J Gastrointest Surg 2010 14 462 469 10.1007/s11605-009-1113-2 19937473
15. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. RP Tracy RN Lemaitre BM Psaty DG Ives RW Evans M Cushman EN Meilahn LH Kuller, Arterioscler Thromb Vasc Biol 1997 17 1121 1127 9194763
16. Sustain weight loss to downregulate inflammation. R SoRelle, Circulation 2002 105 9075 9076 11854136
17. Weight loss reduces C-reactive protein levels in obese postmenopausal women. A Tchernof A Nolan CK Sites PA Ades ET Poehlman, Circulation 2002 105 564 569 10.1161/hc0502.103331 11827920
18. C-reactive protein levels and radiation-induced mucositis in patients with head-and-neck cancer. Y Ki W Kim J Nam D Kim D Park, Int J Radiat Oncol Biol Phys 2009 75 393 398 19362778